Suchergebnisse - (Subject:"antiviral")

PubPharm (256)

1

Pegylated interferon-α for chronic hepatitis B … not ready to be shelved yet! New insights on its role using single-cell transcriptomics

enthalten in: Hepatology (Baltimore, Md.) | 2024

von Gill, U. | Peppa, D.

2

Clinical trials in hepatitis D virus : Measuring success

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Da, B.

CommentIn: Hepatology. 2023 Jun 1;77(6):E178-E179. - PMID 36976543

3

Treatment of chronic hepatitis D with peginterferon lambda-the phase 2 LIMT-1 clinical trial

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Etzion, O. | Hamid, S. | Lurie, Y. | +12

4

Making child's play of tolerance : Defining the immune-viral interplay during combination entecavir and pegylated interferon therapy for immune-tolerant hepatitis B infection

enthalten in: Hepatology (Baltimore, Md.) | 2022

von Howell, J. | Hellard, M.

CommentOn: Hepatology. 2022 Sep;76(3):775-787. - PMID 35188674

5

Combination of Entecavir/Peginterferon Alfa-2a in Children With Hepatitis B e Antigen-Positive Immune Tolerant Chronic Hepatitis B Virus Infection

enthalten in: Hepatology (Baltimore, Md.) | 2019

von Rosenthal, P. | Ling, S. | Belle, S. | +7

CommentIn: Hepatology. 2019 Jun;69(6):2315-2317. - PMID 30964209

6

Efficacy and Safety of Peginterferon Alfa-2a (40KD) in Children With Chronic Hepatitis B : The PEG-B-ACTIVE Study

enthalten in: Hepatology (Baltimore, Md.) | 2018

von Wirth, S. | Zhang, H. | Hardikar, W. | +13

7

Sofosbuvir, pegylated interferon, and ribavirin for retreatment of hepatitis C virus genotype 1b following sofosbuvir and ledipasvir failure

enthalten in: Hepatology (Baltimore, Md.) | 2018

von Kalal, C. | Shukla, A. | Mohanka, R. | +3

8

A potent hepatitis B surface antigen response in subjects with inactive hepatitis B surface antigen carrier treated with pegylated-interferon alpha

enthalten in: Hepatology (Baltimore, Md.) | 2017

von Cao, Z. | Liu, Y. | Ma, L. | +6

9

Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection

enthalten in: Hepatology (Baltimore, Md.) | 2015

von Pawlotsky, J. | Flisiak, R. | Sarin, S. | +14

10

Effect of interferon-alpha therapy on hepatitis D virus

enthalten in: Hepatology (Baltimore, Md.) | 2015

von Goyal, A. | Murray, J.

CommentOn: Hepatology. 2014 Dec;60(6):1902-10. - PMID 25098971

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[26]